wada aod9604 prohibited list 2025 Reminder: WADA's comes into force on 1 January AOD-9604: Lessons from a discontinued

MOR, M., KENLEY, D

For researchers whose metabolic study programme also involves growth factor signalling alongside lipolysis research, our IGF-1 LR3 1mg research guide covers the growth factor peptide most commonly used as a mechanistic counterpart to AOD-9604, operating through the IGF-1 receptor pathway rather than the beta-3 adrenergic system, providing a complementary non-overlapping molecular probe for multi-pathway metabolic studies

In our experience, if you use proper sterile procedures and refrigerated storage, you can continue sampling from the same reconstituted vial for 3+ months

These injections prevent the accumulation of fats in the liver and increase your daily energy level

Consult qualified healthcare professionals before beginning any peptide protocol